Exact Mass: 364.1212
Exact Mass Matches: 364.1212
Found 500 metabolites which its exact mass value is equals to given mass value 364.1212
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
10-HCPT
10-Hydroxycamptothecin is a pyranoindolizinoquinoline. 10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)). 10-Hydroxycamptothecin is a natural product found in Nothapodytes nimmoniana, Camptotheca acuminata, and Fusarium solani with data available. D000970 - Antineoplastic Agents (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4]. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4].
Pyridaben
CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10598; ORIGINAL_PRECURSOR_SCAN_NO 10596 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10636; ORIGINAL_PRECURSOR_SCAN_NO 10634 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10546; ORIGINAL_PRECURSOR_SCAN_NO 10544 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10660; ORIGINAL_PRECURSOR_SCAN_NO 10659 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10708; ORIGINAL_PRECURSOR_SCAN_NO 10707 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10670; ORIGINAL_PRECURSOR_SCAN_NO 10667 CONFIDENCE standard compound; INTERNAL_ID 2632
bumetanide
D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors C - Cardiovascular system > C03 - Diuretics > C03C - High-ceiling diuretics > C03CA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators KEIO_ID B093; [MS2] KO009094 KEIO_ID B093; [MS3] KO009095 KEIO_ID B093
Bumetanide
Bumetanide is only found in individuals that have used or taken this drug. It is a sulfamyl diuretic.Bumetanide interferes with renal cAMP and/or inhibits the sodium-potassium ATPase pump. Bumetanide appears to block the active reabsorption of chloride and possibly sodium in the ascending loop of Henle, altering electrolyte transfer in the proximal tubule. This results in excretion of sodium, chloride, and water and, hence, diuresis. D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors C - Cardiovascular system > C03 - Diuretics > C03C - High-ceiling diuretics > C03CA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
hydroxytorsemide
hydroxytorsemide is a metabolite of torasemide. Torasemide or torsemide is a pyridine-sulfonyl urea type loop diuretic mainly used in the management of edema associated with congestive heart failure. It is also used at low doses for the management of hypertension. It is marketed under the brand name Demadex and Diuver. Compared to other loop diuretics, torasemide has a more prolonged diuretic effect than equipotent doses of furosemide and relatively decreased potassium-loss. (Wikipedia)
(1R,4Ar,5S,7R)-7-methyl-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol
10-Hydroxycamptothecin
N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide
Clofoctol
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use C254 - Anti-Infective Agent > C52588 - Antibacterial Agent Clofoctol is a bacteriostatic antibiotic. Clofoctol is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. Clofoctol is only functional against Gram-positive bacteria and can penetrate into human lung tissue. Clofoctol is also an inhibitor of prostate cancer. Clofoctol has antiviral potency[1][2][3].
Diaziquone
N'-[2-(3,5-Difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide
(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea
Lykurim
D000970 - Antineoplastic Agents
Pheneticillin
N-[(Furan-2-yl)methyl]-2-(N-methyl-2-phenoxyacetamido)benzamide
Ajugol
Harpagide is a natural product found in Scrophularia leucoclada, Scrophularia variegata, and other organisms with data available. See also: Harpagophytum zeyheri root (part of). Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2]. Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2].
harpagide
Origin: Plant; SubCategory_DNP: Monoterpenoids, Harpagide monoterpenoids Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2]. Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2].
Carpachromene dimethyl ether
3,5-Dimethoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one
3,6-Dimethoxy-6,6-dimethylpyrano[2,3:7,8]flavone
18-bromooctadeca-5,7,17-triynoic acid methyl ester
5,6,7,8-tetrahydroxy-2-(3-hydroxy-4-methoxyphenethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one
1,3-Bis-(1-semicarbazono-2-carboxy-aethyl)-benzol|3,3-Disemicarbazono-3,3-m-phenylen-di-propionsaeure|3,3-disemicarbazono-3,3-m-phenylene-di-propionic acid
(-)-(5R,6S)-5-carbamoyl-5-beta-D-glucopyranosyloxy-6-hydroxy-4-methoxy-1-methyl-5,6-dihydro-2-pyridone|acalyphin amide
(8S)-(-)-7,8-Dihydro-8-hydroxyaucubin|5,7-bisdeoxy-cynanchoside|5,7-bisdeoxycynanchoside
C1=CC(O)=C2C(OC)C(OC)C3C4=CC=C(O)C(C(=O)CC5)=C4C5=C3C2=C1
3-ethoxy-1,4,9-trihydroxy-1,2,3,6b-tetrahydrobenzo[j]fluoranthen-8(7H)-one|hypoxylonol A
methyl ester of 18-bromooctadeca-5,7,17-triynoic acid
Me ether-(15Z,17E)-18-Bromo-15,17-octadecadiene-5,7-diynoic acid|Methyl 18-Bromo-(15Z,17E)-octadeca-15,17-diene-5,7-diynoate
2-{6-[3,4-(methylenedioxy)phenyl]-4-oxotetracyclo[5.4.2.0(3,13).0(10,12)]-trideca-5,8-dien-11-yl}acetic acid|5-(1,3-benzodioxol-5-yl)-1a,2,2a3,5a,7a,7b,7c-octahydro-3-oxo-1H-cyclobut[bc]acenaphthylene-1-acetic acid|beilschmiedic acid F
1S,2R,3R,4S-2-[(benzoyloxy)methyl]cyclohex-5-ene-1,2,3,4-tetrol 1,4-diacetate
(Z)-methyl 7-{(cinnamoyloxy)methyl}-3,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octane-3-carboxylate|decurrenside C
(3S,4R)-4,7,1?4-tetrahydroxy-6,2,3-trimethoxyisoflavan|abruquinone K
(1S,3R,5R,7S,8S,9S)-1,3-diethoxy-5,8-dihydroxyvalechlorine|chlorovaltrate D
4,5,7-trihydroxy-6-isopentene-2-styrylchromone|platachromone A
4,5,7-trihydroxy-8-isopentene-2-styrylchromone|platachromone B
(5S)-5-(8-{[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octa-2,4,6-triyn-1-yl)dihydrofuran-2(3H)-one|3,4-dihydrovernoniyne-8-O-beta-glucoside
4-O-demethylhypothemycin|4-O-desmethylhypothemycin
4-Ethyl-4,12-dihydroxy-1H-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
2-Phenyl-7-methoxy-8-(4-oxo-5,5-dimethyl-4,5-dihydrofuran-3-yl)-2,3-dihydro-4H-1-benzopyran-4-one
clofoctol
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use C254 - Anti-Infective Agent > C52588 - Antibacterial Agent Clofoctol is a bacteriostatic antibiotic. Clofoctol is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. Clofoctol is only functional against Gram-positive bacteria and can penetrate into human lung tissue. Clofoctol is also an inhibitor of prostate cancer. Clofoctol has antiviral potency[1][2][3].
Hydroxy camptothecine
D000970 - Antineoplastic Agents (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity. (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
10-Hydroxycamptothecin
SubCategory_DNP: : Alkaloids derived from anthranilic acid, Quinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.944 D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.947 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.929 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.928 (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4]. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4].
3-methoxy-4-[2-methoxy-4-(1,2,3-trihydroxypropyl)phenoxy]benzoic acid
methyl 2-(9,10a-dihydroxy-4a-methoxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl)acetate
C15H24O10_4a,5,7-Trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl beta-D-glucopyranoside
7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol
methyl 2-(9,10a-dihydroxy-4a-methoxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl)acetate [IIN-based on: CCMSLIB00000848761]
methyl 2-(9,10a-dihydroxy-4a-methoxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl)acetate [IIN-based: Match]
7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol_major
7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol_57.3\\%
Ala Ala Cys Thr
Ala Ala Thr Cys
Ala Cys Ala Thr
Ala Cys Asp Gly
Ala Cys Gly Asp
Ala Cys Thr Ala
Ala Asp Cys Gly
Ala Asp Gly Cys
Ala Gly Cys Asp
Ala Gly Asp Cys
Ala Gly Met Ser
Ala Gly Ser Met
Ala Met Gly Ser
Ala Met Ser Gly
Ala Ser Gly Met
Ala Ser Met Gly
Ala Thr Ala Cys
Ala Thr Cys Ala
Cys Ala Ala Thr
Cys Ala Asp Gly
Cys Ala Gly Asp
Cys Ala Thr Ala
Cys Asp Ala Gly
Cys Asp Gly Ala
Cys Glu Gly Gly
Cys Gly Ala Asp
Cys Gly Asp Ala
Cys Gly Glu Gly
Cys Gly Gly Glu
Cys Gly Ser Val
Cys Gly Val Ser
Cys Ser Gly Val
Cys Ser Val Gly
Cys Thr Ala Ala
Cys Val Gly Ser
Cys Val Ser Gly
Asp Ala Cys Gly
Asp Ala Gly Cys
Asp Cys Ala Gly
Asp Cys Gly Ala
Asp Gly Ala Cys
Asp Gly Cys Ala
Asp Gly Ser Ser
Asp Ser Gly Ser
Asp Ser Ser Gly
Glu Cys Gly Gly
Glu Gly Cys Gly
Glu Gly Gly Cys
Gly Ala Cys Asp
Gly Ala Asp Cys
Gly Ala Met Ser
Gly Ala Ser Met
Gly Cys Ala Asp
Gly Cys Asp Ala
Gly Cys Glu Gly
Gly Cys Gly Glu
Gly Cys Ser Val
Gly Cys Val Ser
Gly Asp Ala Cys
Gly Asp Cys Ala
Gly Asp Ser Ser
Gly Glu Cys Gly
Gly Glu Gly Cys
Gly Gly Cys Glu
Gly Gly Glu Cys
Gly Gly Met Thr
Gly Gly Thr Met
Gly Met Ala Ser
Gly Met Gly Thr
Gly Met Ser Ala
Gly Met Thr Gly
Gly Ser Ala Met
Gly Ser Cys Val
Gly Ser Asp Ser
Gly Ser Met Ala
Gly Ser Ser Asp
Gly Ser Val Cys
Gly Thr Gly Met
Gly Thr Met Gly
Gly Val Cys Ser
Gly Val Ser Cys
Met Ala Gly Ser
Met Ala Ser Gly
Met Gly Ala Ser
Met Gly Gly Thr
Met Gly Ser Ala
Met Gly Thr Gly
Met Ser Ala Gly
Met Ser Gly Ala
Met Thr Gly Gly
Ser Ala Gly Met
Ser Ala Met Gly
Ser Cys Gly Val
Ser Cys Val Gly
Ser Asp Gly Ser
Ser Asp Ser Gly
Ser Gly Ala Met
Ser Gly Cys Val
Ser Gly Asp Ser
Ser Gly Met Ala
Ser Gly Ser Asp
Ser Gly Val Cys
Ser Met Ala Gly
Ser Met Gly Ala
Ser Ser Asp Gly
Ser Ser Gly Asp
Ser Val Cys Gly
Ser Val Gly Cys
Thr Ala Ala Cys
Thr Ala Cys Ala
Thr Cys Ala Ala
Thr Gly Gly Met
Thr Gly Met Gly
Thr Met Gly Gly
Val Cys Gly Ser
Val Cys Ser Gly
Val Gly Cys Ser
Val Gly Ser Cys
Val Ser Cys Gly
Val Ser Gly Cys
PHENETHICILLIN
A penicillin in which the substituent at position 6 of the penam ring is a 2-phenoxypropanamido group.
4a,5,7-Trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl ?-D-glucopyranoside
2,3-DIPHENYL-5-(4-METHOXYPHENYL)TETRAZOLIUM CHLORIDE
zidometacin
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
ethyl 4-methyl-2-[4-(2-methylpropoxy)-3-nitrophenyl]-1,3-thiazole-5-carboxylate
5-{[1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl}-2-py ridinamine
CDPPB
CDPPB is a potent, selective and brain penetrant positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5), with an EC50 of 27 nM in Chinese hamster ovary cells expressing human mGluR5. CDPPB may provide an approach for development of antipsychotic agents[1].
5-fluoro-o4-(2,4,6-trimethylphenyl)-2-deoxyuridine
pheneticillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene,oxepan-2-one
Diaziquone
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
3,14-Dioxa-2,15-dithia-6,11-diazahexadecane-8,9-diol,2,2,15,15-tetraoxide, (8R,9S)-rel-
Levomepromazine hydrochloride
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine
1-(2,4-bis-(Benzyloxy)-3,6-dihydroxyphenyl)ethanone
Tiapride hydrochloride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants Tiapride hydrochloride is a selective and orally active D2 and D3 dopamine receptors antagonist with IC50 values of 110-320 nM and 180 nM, respectively. Tiapride hydrochloride shows anti-dyskinetic activity and anxiolytic activity. Tiapride hydrochloride is a neuroleptic agent[1][2].
[(1S,2S,6R)-5,6-diacetyloxy-1,2-dihydroxy-1-cyclohex-3-enyl]methyl ben zoate
N-Acetyl-α-cyano-p-benzoyl-D,L-phenylalanine, Ethyl Ester
ethyl 2-[3-(1H-benzimidazol-2-yl)-2-oxochromen-7-yl]oxyacetate
5-(2-Oxo-hexahydro-thieno[3,4-D]imidazol-6-YL)-pentanoic acid (4-nitro-phenyl)-amide
(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea
N-(2-(3,5-difluorophenyl)-2-hydroxyacetyl)-2-ethyl-4-hydroxy-3-methylbenzohydrazide
[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl](1-benzofuran-2-yl)methanone
(E)-[4-(3,5-Difluorophenyl)-3h-Pyrrolo[2,3-B]pyridin-3-Ylidene](3-Methoxyphenyl)methanol
N1-(1-benzyl-4-piperidyl)-4-chlorobenzene-1-sulfonamide
2-[[(3-Methylphenyl)-oxomethyl]amino]benzoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester
2-[[2-(4-ethyl-4-methyl-2,5-dioxo-1-imidazolidinyl)-1-oxoethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide
1-(3,4-dihydro-2H-quinolin-1-yl)-2-[(4-methyl-5-phenyl-1,2,4-triazol-3-yl)thio]ethanone
3,5-Dimethyl-4-isoxazolecarboxylic acid [2-(4-amino-1-methyl-2,6-dioxo-3-propyl-5-pyrimidinyl)-2-oxoethyl] ester
N-[3-[[2-(2,6-dimethylphenoxy)-1-oxoethyl]amino]phenyl]-2-furancarboxamide
N-(6-methyl-1,3-benzothiazol-2-yl)-6-oxo-1-phenyl-4,5-dihydropyridazine-3-carboxamide
3-ethyl-2-{[(4-hydroxy-2-quinazolinyl)methyl]thio}-4(3H)-quinazolinone
3-(Benzenesulfonyl)-1-cyclopropyl-2-pyrrolo[3,2-b]quinoxalinamine
2-[[5-(2-Benzofuranyl)-4-(phenylmethyl)-1,2,4-triazol-3-yl]thio]acetamide
(+)-(7S,8S)-guaiacylglycerol-beta-vanillic acid ether
A natural product found in Sinocalamus affinis.
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide
cyclobutyl-[(2R,3R)-2-(hydroxymethyl)-6-methylsulfonyl-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]methanone
methyl 2-(9,10a-dihydroxy-4a-methoxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl)acetate
cyclobutyl-[(2S,3R)-2-(hydroxymethyl)-6-methylsulfonyl-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]methanone
(2S,5S,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
propan-2-yl 4-[(4E)-4-[(E)-3-(furan-2-yl)prop-2-enylidene]-3-methyl-5-oxopyrazol-1-yl]benzoate
4-[(3S)-3-benzylpyrrolidin-1-yl]-5-chloro-6-methyl-2-pyridin-2-ylpyrimidine
4-Methoxycarbonyl-5-phenyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis)
2,3,7-Triacetoxy-5-(1,1-dimethyl-2-oxopropyl)-2,4,6-cycloheptatrien-1-one
3-Methoxy-4-[2-methoxy-4-(1,2,3-trihydroxypropyl)phenoxy]benzoic acid
hydroxy torasemide
An aromatic primary alcohol resulting from the hydroxylation of the 3-methyl group of the phenyl ring of torasemide. It is a metabolite of torasemide.
4-hydroxy torasemide
A member of the class of phenols that is torasemide which carries a hydroxy group at position 4 of the phenyl ring. It is a metabolite of torasemide.
Deschloroclozapine (dihydrochloride)
Deschloroclozapine dihydrochloride, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively. [11C]-Deschloroclozapine is developed as a promising PET tracer for DREADD imaging[1][2][3].
MAGL-IN-4
MAGL-IN-4 is an orally active, selective and reversible monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 6.2 nM. MAGL-IN-4 can penetrate the blood-brain barrier (BBB). MAGL-IN-4 enhances endocannabinoid signaling mostly by the increase in the level of 2-AG via selective MAGL inhibition in the brain[1].
(1r,4ar,6r,8ar)-1-bromo-8a-methyl-6-[(2e,4e)-6-methylhepta-2,4,6-trien-2-yl]-4-methylidene-hexahydro-1h-naphthalen-4a-ol
3-[(4-hydroxyphenyl)methylidene]-5-methoxy-6-[(4-methoxyphenyl)methylidene]-1-methylpyrazin-2-one
methyl (17e)-18-bromooctadeca-15,17-dien-5,7-diynoate
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,4as,5r)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl benzoate
methyl (1s,3r,5r,7r,8s)-3,8-dihydroxy-7-({[(2z)-3-phenylprop-2-enoyl]oxy}methyl)-2,6-dioxabicyclo[3.2.1]octane-3-carboxylate
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-{[(1s,4as,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-({4a,6,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
5-(1,2-dihydroxyethyl)-10,15-dimethyl-3,6,13,17-tetraoxahexacyclo[8.7.1.0²,⁴.0⁴,⁹.0¹²,¹⁴.0¹⁵,¹⁸]octadec-8-ene-7,16-dione
[(1s,2s,5s,6r)-2,5-bis(acetyloxy)-1,6-dihydroxycyclohex-3-en-1-yl]methyl benzoate
2-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one
[(1s,2s,3r,6r,10r,11s,12s)-7-(2h-1,3-benzodioxol-5-yl)-9-oxotetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,7-dien-2-yl]acetic acid
(3r,6s)-6-(hydroxymethyl)-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3-(methylsulfanyl)-6h-pyrazine-2,5-diol
6,7,16,18-tetrahydroxy-12-methyl-3,13-dioxatricyclo[13.4.0.0²,⁴]nonadeca-1(19),9,15,17-tetraene-8,14-dione
(2e,3r,4e)-3-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-4-formyl-2-(hydroxymethylidene)hex-4-enoic acid
(5z)-4-hydroxy-3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methylidene]furan-2-one
(2r,4r,6s,7s,9z,12s)-6,7,16,18-tetrahydroxy-12-methyl-3,13-dioxatricyclo[13.4.0.0²,⁴]nonadeca-1(19),9,15,17-tetraene-8,14-dione
[(1s,2r,5r,6s)-5,6-bis(acetyloxy)-1,2-dihydroxycyclohex-3-en-1-yl]methyl benzoate
18-hydroxycamptothecin
{"Ingredient_id": "HBIN002135","Ingredient_name": "18-hydroxycamptothecin","Alias": "NA","Ingredient_formula": "C20H16N2O5","Ingredient_Smile": "C1C2=CC3=CC=CC=C3N=C2C4=CC5=C(COC(=O)C5(CCO)O)C(=O)N41","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9882","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}